The iLite® RANKL assay is ideal for potency measurements of anti-RANKL candidate drugs and studies of RANKL or RANKL agonists. As an added benefit, the RANKL iLite assay contains a luciferase normalization gene which can be used to compensate for differences in cell number and viability as well as serum matrix effects.
In this performance data file, we present data for the RANKL cell line generated throughout the quality assessment process of the product. This data shows that the assays are reliable, accurate, and reproducible - and helps keep errors resulting from biological variation and methodology at a minimum.